Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

August 14, 2018 - 5:01 p.m.
Gilead Sciences Announces Executive PromotionsPrinter Friendly Version 
August 06, 2018 - 6:10 a.m.
China National Drug Administration Approves Gilead’s Genvoya® (Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide), a Single Tablet Regimen for the Treatment of HIV-1 InfectionPrinter Friendly Version 

Upcoming Events

There are currently no events scheduled.

Most Viewed Links

Updated 05/19/18
1.SEC Filings
2.Annual Reports
3.Earnings
4.Fundamentals - Snapshot
5.Stock Information
* Data collected 05/11/18 - 05/18/18

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$75.59
 Stock is Up 0.75 (1.00%)
Data as of 08/16/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Second Quarter 2018 Gilead Sciences Earnings Conference Call

July 25, 2018 2:00 p.m. PT
Play
Gilead Sciences at the Goldman Sachs 39th Annual Global Healthcare Conference

June 13, 2018 8:40 a.m. PT
Play
Gilead Sciences at Jefferies 2018 Global Healthcare Conference

June 06, 2018 10:30 a.m. ET
Play
Gilead Sciences at the Bank of America Merrill Lynch Healthcare Conference

May 16, 2018 9:20 a.m. PT
Play